Peter A. McCue

15.5k total citations · 4 hit papers
182 papers, 11.3k citations indexed

About

Peter A. McCue is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter A. McCue has authored 182 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 52 papers in Oncology and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter A. McCue's work include Prostate Cancer Treatment and Research (18 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Genetics and Neurodevelopmental Disorders (15 papers). Peter A. McCue is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Genetics and Neurodevelopmental Disorders (15 papers). Peter A. McCue collaborates with scholars based in United States, Australia and United Kingdom. Peter A. McCue's co-authors include Kumar Sharma, Stephen Dunn, Michael J. Mastrangelo, Teresa Druck, Carlo M. Croce, Leonard G. Gomella, Zurab Siprashvili, Kay Huebner, Henry Maguire and Agnieszka K. Witkiewicz and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Peter A. McCue

181 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers

1996 884 citations Masataka Ohta, Raffaele Baffa et al. profile →
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

2015 784 citations Agnieszka K. Witkiewicz, Uthra Balaji et al. profile →
Adiponectin regulates albuminuria and podocyte function in mice

2008 498 citations Peter A. McCue et al. profile →
GATA3

2013 469 citations Peter A. McCue et al. The American Journal of Surgical Pathology profile →

Peers

Peter A. McCue

ONCOL

GENET

PRM

Yusuke Nakamura Japan

Marc K. Halushka United States

Norio Nonomura Japan

Bin Tean Teh United States

Beth Y. Karlan United States

Hans Jørgen Nielsen Denmark

Bhuvanesh Singh United States

Naoyuki Kamatani Japan

Christian Marth Austria

Maria Tretiakova United States

Yusuke Nakamura Japan

Peter A. McCue

4.6k ×0.9

2.1k ×0.6

ONCOL

1.8k ×0.8

GENET

1.5k ×0.7

1.1k ×0.5

PRM

Citations per year, relative to Peter A. McCue Peter A. McCue (= 1×) peers Yusuke Nakamura

Countries citing papers authored by Peter A. McCue

Since Specialization

Citations

This map shows the geographic impact of Peter A. McCue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. McCue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. McCue more than expected).

Fields of papers citing papers by Peter A. McCue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. McCue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. McCue. The network helps show where Peter A. McCue may publish in the future.

Co-authorship network of co-authors of Peter A. McCue

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. McCue. A scholar is included among the top collaborators of Peter A. McCue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. McCue. Peter A. McCue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishn, Shiv Ram, George G. Daaboul, Raffaella Pippa, et al.. (2020). Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells. Journal of Extracellular Vesicles. 9(1). 1761072–1761072. 32 indexed citations

Chen, Ke, Xuanmao Jiao, Anthony W. Ashton, et al.. (2020). The membrane-associated form of cyclin D1 enhances cellular invasion. Oncogenesis. 9(9). 83–83. 21 indexed citations

Krishn, Shiv Ram, Ekta Agarwal, Qin Liu, et al.. (2020). The αvβ6 integrin in cancer cell‐derived small extracellular vesicles enhances angiogenesis. Journal of Extracellular Vesicles. 9(1). 49 indexed citations

Trabulsi, Edouard J., Brian Calio, Sarah Kamel, et al.. (2019). Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation. Urology. 133. 187–191. 7 indexed citations

Calio, Brian, Sandeep Deshmukh, Donald G. Mitchell, et al.. (2019). Spatial distribution of biopsy cores and the detection of intra-lesion pathologic heterogeneity. Therapeutic Advances in Urology. 11. 2078064053–2078064053. 8 indexed citations

Capparelli, Claudia, Timothy J. Purwin, Inna Chervoneva, et al.. (2018). ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Research. 78(19). 5680–5693. 13 indexed citations

Hutcheson, Jack, Uthra Balaji, Matthew R. Porembka, et al.. (2016). Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. Clinical Cancer Research. 22(14). 3606–3617. 65 indexed citations

McCue, Peter A., et al.. (2016). Intraoperative Frozen Section Analysis of the Pancreas: A Case Report and Review of the Literature. PubMed. 2(1). 71–74. 3 indexed citations

Cheng, Hanyin, Mizue Terai, Ken Kageyama, et al.. (2015). Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma. Cancer Research. 75(13). 2737–2748. 53 indexed citations

10.

Gu, Lei, Zhiyong Liao, David T. Hoang, et al.. (2013). Pharmacologic Inhibition of Jak2–Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 19(20). 5658–5674. 48 indexed citations

11.

Comstock, Clay E.S., Adam Ertel, Kwang Won Jeong, et al.. (2013). Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes. Clinical Cancer Research. 19(10). 2657–2667. 31 indexed citations

12.

Ju, Xiaoming, Adam Ertel, Mathew C. Casimiro, et al.. (2012). Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures. Cancer Research. 73(2). 978–989. 16 indexed citations

13.

Wu, Kongming, Sanjay Katiyar, Agnes Witkiewicz, et al.. (2009). The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth. Cancer Research. 69(8). 3347–3355. 66 indexed citations

14.

Ren, Qing, Csaba Kari, Marlene R.D. Quadros, et al.. (2006). Malignant Transformation of Immortalized HaCaT Keratinocytes through Deregulated Nuclear Factor κB Signaling. Cancer Research. 66(10). 5209–5215. 45 indexed citations

15.

Turner, Bruce, Michelle Ottey, Drazen B. Zimonjic, et al.. (2002). The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.. PubMed. 62(14). 4054–60. 47 indexed citations

16.

Capuzzi, David M., Walter W. Hauck, Albert J. Kovatich, et al.. (2000). Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.. PubMed. 88(1). 24–34. 54 indexed citations

17.

Ingvarsson, Sigurður, Bjarni A. Agnarsson, Juha Kononen, et al.. (1999). Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.. PubMed. 59(11). 2682–9. 40 indexed citations

18.

Hadaczek, Piotr, Zurab Siprashvili, Maciej M. Markiewski, et al.. (1998). Absence or reduction of Fhit expression in most clear cell renal carcinomas.. PubMed. 58(14). 2946–51. 69 indexed citations

19.

O’Hara, Brian J., Peter A. McCue, & Markku Miettinen. (1992). Bile Duct Adenomas With Endocrine Component. The American Journal of Surgical Pathology. 16(1). 21–25. 12 indexed citations

20.

Rifkin, Matthew D., et al.. (1992). MR imaging characteristics of noncancerous lesions of the prostate. Journal of Magnetic Resonance Imaging. 2(1). 35–39. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact